跳转到文章内容

An innovation can often build upon an existing technology to make it more practical in the real world. From autonomous weeding systems that adapt on the fly, to engineered cells designed to evade immune system attack, to water infrastructure that harnesses the physics of the deep sea, this quarter’s selections remove bottlenecks to bring promising technologies closer to widespread use. While their applications differ, each reflects a broader pattern: Innovation often advances by transforming abstract ideas into usable machines or systems.

Farm robots use artificial intelligence (AI) to “see” weeds           

An agricultural robotics company recently introduced a new AI model that enables its laser-weeding machines to identify plant species in real time, helping farmers discern crops from weeds. Earlier systems were more rigid. New weed species and shifting field conditions often required another round of labeling and retraining. The new system is built on a much more comprehensive plant-recognition model and can be adjusted in the field using a few example images, allowing the machine to adapt in minutes rather than undergoing a separate lengthy retraining cycle.1

Why it matters:

Precision agriculture promises lower chemical use and less manual labor, but frequent retraining has made autonomous weeding harder to scale. That matters because uncontrolled weeds have the potential to cut corn yields by about 50% and soybean yields by about 52% in the United States and Canada, costing growers nearly US$44 billion annually. Systems that use software to adapt in the field could make robotic crop management more practical.2

AI Powers Automatic Laser-weeding on Farms

AI-powered robotic arms use laser precision to identify and remove weeds among growing crops, showcasing the future of smart farming.

For illustrative purposes only.

Engineered cell therapy moves closer to a Type 1 diabetes cure

Researchers reported in early 2025 a result from a human trial showing that a person with Type 1 diabetes began producing insulin after receiving cellular therapy. In this case, insulin-producing cells, known as islet cells, were transplanted into the patient. These cells were specifically designed to avoid immune system attacks. That is notable because the cells appeared to work without the anti-rejection drugs transplants normally require.3

Why it matters:

Type 1 diabetes affects 9.2 million people worldwide, but replacing the insulin-producing cells destroyed by the disease has usually required anti-rejection drugs that carry their own risks and limitations regarding who can receive treatment. A therapy that works without anti-rejection drugs would remove one of the biggest barriers to making cell replacement a practical path toward a functional cure.4

Light-activated pacemaker dissolves after use

Researchers have developed a temporary pacemaker smaller than a grain of rice that can be injected by syringe and activated by light. Instead of wires and an external battery, the device uses tiny electrodes and the body’s own biofluids to generate power, while a soft wearable patch on the chest detects irregular heartbeats and sends near-infrared light pulses to trigger pacing. After a few days to a few weeks, the pacemaker naturally dissolves.5

Why it matters:

Temporary pacemakers are often needed after surgery, but current systems require wires that can cause infection, bleeding and tissue damage when removed. That is especially important for newborns: congenital heart defects affect nearly 1% of US births, or about 40,000 babies each year, and about one in four cases are critical. A dissolvable device could make short-term cardiac care less invasive.6

A new desalination plant works underwater

A subsea desalination system places reverse-osmosis infrastructure hundreds of meters below the ocean surface to produce freshwater. At those depths, the ocean’s own pressure helps push seawater through the filters and reduces the need for large high-pressure pumps and bulky land-based facilities. Developers say the design could reduce energy use significantly, shrink coastal land requirements and simplify filtration processes.7

Why it matters:

2.2 billion people still lacked safely managed drinking water in 2024. Traditional desalination works, but its high energy use and coastal footprint have limited how broadly it can help address water scarcity. If subsea systems can lower the cost, energy burden and land footprint of desalination, they could make reliable water access more practical for water-stressed coastal regions and water-intensive industries such as semiconductors, data centers, and mining.8

AI may help solve more crimes in the United States

A public safety technology provider is using AI to make license plate camera networks more searchable for investigators. Rather than simply reading plates, the AI tools let investigators search for vehicles using plain-language descriptions and unique visual characteristics, making camera footage much easier to use in real investigations.9 The company reported in 2024 that its platform helped solve more than 700,000 crimes annually, which would translate to roughly 10% of reported US crime.10

Why it matters:

AI could turn camera networks from passive recording tools into active investigative search tools. In 2024, only 43.8% of violent crimes and 15.9% of property crimes were cleared nationwide. Systems that let investigators search for footage using plain-language vehicle descriptions could help turn more camera data into real leads and help solve more crimes.11

Companies referenced are for illustrative purposes only and are not recommendations or indications of trading intent of Franklin Templeton. No assurance can be given that any forecast, projection or prediction regarding economies or financial markets will be realized.



Copyright ©2025 富蘭克林鄧普頓。版權所有。

本文件僅供一般參考。本文件不應被視作個人投資建議或買賣或持有任何基金股份或證券的要約或招攬。有關本文所提及的任何證券的資料並不足以用作制定投資決策。投資涉及風險。投資價值可升或跌,過往業績不代表或不保證將來的表現。投資收益是以資產淨值計算,已考慮股息再投資及資本增長或損失。投資收益以所示貨幣計價,該等貨幣可能是美元/港元以外的貨幣(「外幣」)。因此,以美元/港元交易的投資者需承受美元/港元與外幣之間匯率波動的風險。投資者應仔細閱讀銷售文件,以獲取進一步資料,包括風險因素。

本文件所載的數據、評論、意見、預測及其他資料如有更改恕不另行通知。不保證投資產品目標將會實現,亦不保證所示預測將會實現。表現亦可能受貨幣波動影響。流動性下降或會對資產價格產生不利影響。貨幣波動可能會影響海外投資的價值。如果投資產品投資於新興市場,風險可能高於投資於已發展市場。如果投資產品投資於衍生工具,則需承擔特定風險,這可能會增加投資產品承受的風險水平。如果投資產品投資於特定行業或地區,回報的波動程度可能高於更多元化的投資產品投資。富蘭克林鄧普頓不就使用本文件或其所載的任何評論、意見或估計而導致的任何直接或間接後果性損失承擔任何責任。在未得到富蘭克林鄧普頓的事先書面同意下,不得以任何方式複製、派發或發表本文件。

名稱中包含「(已對沖)」的任何股份類別將嘗試對沖本基金基礎貨幣與股份類別計值貨幣之間的貨幣風險,但不保證可以成功對沖。在某些情況下,投資者可能涉及額外風險。

若閣下對其中任何資料有疑問,謹請與閣下的財務顧問聯絡。

只適用於UCITS基金: 此外,投資者權利概要可從這裡獲得。根據 UCITS 指令,基金/子基金被通知在不同地區進行營銷。 基金/子基金可以使用 UCITS 指令第 93a 條中包含的程序隨時終止任何股份類別和/或子基金的此類通知。

只適用於AIFMD基金:此外,投資者權利摘要可從這裡獲得。根據 AIFMD 指令,基金/子基金被通知在不同地區進行營銷。 基金/子基金可以使用 AIFMD指令第 32a 條中包含的程序隨時終止任何股份類別和/或子基金的此類通知。

為避免疑問,如果您決定投資,即代表您將購買本基金的單位/股份,並不是直接投資於本基金的相關資產。

本文件由富蘭克林鄧普頓投資(亞洲)有限公司發行,並未為香港證監會所審閱。

除非另有註明,所有資料截至上述日期。資料來源:富蘭克林鄧普頓。

CFA® 及Chartered Financial Analyst®為特許金融分析師協會擁有的商標。